Top Markets
Coin of the day
China Chemical & Pharmaceutical Co., Ltd. China Chemical & Pharmaceutical Co., Ltd.

China Chemical & Pharmaceutical Co., Ltd.

1701
Κατάταξη σε μετοχές #18552
China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan,... China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan, in 1952, is a prominent player in the pharmaceutical sector. The company specializes in the research, development, manufacturing, and distribution of generic pharmaceutical and healthcare products, serving both human and animal health markets. Its extensive human pharmaceutical portfolio encompasses a wide array of therapeutic areas. Key offerings include medications for cardiovascular health (such as treatments for heart conditions, cholesterol management, and peripheral circulation disorders), metabolic conditions (including diabetes, weight management, and corticosteroid therapies), and infectious diseases (like antibiotics, antifungals, and antivirals). CCP also provides a range of nutritional supplements, from vitamins and hepatic support agents to electrolyte and caloric preparations. Other significant categories cover pain and inflammation relief (antipyretics, analgesics, anti-inflammatories), digestive system remedies (gastrointestinal drugs, gut health enhancers, antispasmodics), and respiratory treatments (antitussives, antihistamines, and asthma medications). Furthermore, the company produces drugs addressing urological issues (specifically for benign prostatic hyperplasia), central nervous system disorders (hypnotics, mood stabilizers, and antidepressants), and critical areas like hematology and oncology, alongside other general preparations and sexual well-being products. Beyond prescription medications, CCP's non-prescription (OTC) division offers popular consumer health products, such as vitamins, topical skincare items, cold and cough remedies, anti-inflammatory pain relievers, and digestive aids. The company additionally supplies antibacterial and disinfectant solutions. In the animal health sector, CCP manufactures veterinary pharmaceuticals catering to livestock (pigs and cattle), poultry, and companion animals, alongside various feed supplements. Rounding out its operations, China Chemical & Pharmaceutical Co., Ltd. offers contract manufacturing services to other industry players.
Τιμή μετοχής
$0.65890555
Τελευταίος συγχρονισμός: 2024-09-03
Κεφαλαιοποίηση
$194.28M
Αλλαγή (1 ημέρα)
-0.07%
Αλλαγή (1 έτος)
0.00%
Χώρα
TW
Εμπόριο China Chemical & Pharmaceutical Co., Ltd. (1701)

Κατηγορία

Η τιμή 1701 με την κεφαλαιοποίηση του Β
China Chemical & Pharmaceutical Co., Ltd. China Chemical & Pharmaceutical Co., Ltd.
1701
$0.65890555
Κεφαλαιοποίηση αγοράς του China Chemical & Pharmaceutical Co., Ltd.(1701)
Κεφαλαιοποίηση: $194.28M
Μέχρι το September 2026, η China Chemical & Pharmaceutical Co., Ltd. έχει χρηματιστηριακή αξία $194.28M. Αυτό καθιστά τη China Chemical & Pharmaceutical Co., Ltd. την 18552nd πιο πολύτιμη εταιρεία στον κόσμο βάσει της κεφαλαιοποίησης σύμφωνα με τα δεδομένα μας. Η χρηματιστηριακή κεφαλαιοποίηση είναι η συνολική αγοραία αξία των μετοχών μιας εισηγμένης εταιρείας και χρησιμοποιείται συνήθως για να προσδιοριστεί η αξία μιας εταιρείας.
Ιστορικό κεφαλαιοποίησης αγοράς της China Chemical & Pharmaceutical Co., Ltd. από 2000 έως 2026
1701 σε σύγκριση με τα 5 πιο δημοφιλή stocks
Η τιμή για 1701 Το περιουσιακό στοιχείο B Η κεφαλαιοποίηση αγοράς του B Αποτελέσματα
China Chemical & Pharmaceutical Co., Ltd. China Chemical & Pharmaceutical Co., Ltd.
$18,396.57 $194.28M
$5.424T +2,791,888.99%
China Chemical & Pharmaceutical Co., Ltd. China Chemical & Pharmaceutical Co., Ltd.
$16,197.49 $194.28M
$4.776T +2,458,142.13%
China Chemical & Pharmaceutical Co., Ltd. China Chemical & Pharmaceutical Co., Ltd.
$13,741.79 $194.28M
$4.052T +2,085,447.27%
China Chemical & Pharmaceutical Co., Ltd. China Chemical & Pharmaceutical Co., Ltd.
$12,518.21 $194.28M
$3.691T +1,899,749.46%
China Chemical & Pharmaceutical Co., Ltd. China Chemical & Pharmaceutical Co., Ltd.
$9,307.14 $194.28M
$2.744T +1,412,415.60%